Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Maves vs Recovery Delivered

Maves
Graded #88

Higher grade

vs+11.099999999999994
Recovery Delivered
Graded #318

Lower grade

The verdict

Maves takes it — 71.8/100 to 60.7/100.

Maves grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging, with…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaves +38
84
46
Dose & formulationEven
65
65
Clinical oversightMaves +1
76
75
Labs & monitoringEven
52
52
FulfillmentMaves +12
87
75
Contract termsEven
55
55
Maves · left barRecovery Delivered · right bar

The numbers

MetricMavesRecovery Delivered
WeighScore71.8/10060.7/100
GradeCC
Scorecard rank#88#318
Semaglutide$99/mo (starting dose, first-month rate, compounded)$199/mo (starting dose, compounded)
TirzepatideNot disclosed$219/mo (2.5 mg dose, compounded)
CoverageAll 50 states32 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Maves

Graded #88 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed
Recovery Delivered

Graded #318 · C

Strengths

  • Low entry price: compounded semaglutide from $199.99/mo, tirzepatide from $219/mo
  • Video visit with a provider and home delivery included in the price
  • Offers both injectable and oral compounded GLP-1 options

Where it loses points

  • Compounding pharmacy is not publicly named
  • Not available in 19 states (including CA, IL, TN, GA, MI)
  • Higher semaglutide doses cost up to $299.99/mo

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard